Fundus autofluorescence. Lippincott William and 
Wilkins, Baltimore: 3–13
Shields C, Pirondini C, 
Bianciotto C, Materin MA, 
Harmon SA, Shields JA 
(2008) Autofluorescence 
in choroidal nevus in 64 
cases. Retina 28: 1035–43
Shields CL, Furuta M, Berman 
EL et al (2009) Choroidal 
nevus transformation into 
melanoma: analysis of 2514 
consecutive cases. Arch 
Ophthalmol 127: 981–7
Smith RT (2010) The normal 
distribution of fundus 
autofluorescence. In: Lois 
N and Forrester JV, eds. Fundus autofluorescence. Lippincott William and 
Wilkins, Baltimore: 99–104
Smith RT, Chan JK, Busuoic 
M, Sivagnanavel V, Bird 
AC, Chong NV (2006) 
Autofluorescence charac-
teristics of early, atrophic, 
and high-risk fellow eyes 
in age-related macular 
degeneration. Investigative 
Ophthalmol Visual Sci 47: 
5495–504
Viestenz A, Langenbucher A, 
Mardin CY (2006) Peripap-
illary autofluorescence as 
indicator for glaucoma. Klin 
Monbl Augenheilkd 223: 
315–20
Vujosevic S, Casciano M, 
Pilotto E, Boccassini B, 
Varano M, Midena E (2011) 
Diabetic macular edema: 
fundus autofluorescence 
and functional correlations. Investigative Ophthalmol 
Visual Sci 52: 442–8
Weiter JJ, Delori FC, Wing 
GL, Fitch KA (1986)
Retinal pigment epithelial 
lipofuscin and melanin 
and choroidal melanin in 
human eyes. Investigative 
Ophthalmol Visual Sci 27: 
145–52
References
choroidal nevi are to be found in 5–10% of cauca-
sians (Kanski, 2007) the extra information given 
by FAF imaging makes it useful in an ophthalmic 
setting. Shields et al (2008) suggested that hyperfluo-
rescent FAF shows recent changes in the nevus that 
calls for attention while hypofluorescent FAF indi-
cates a more stable nevus. Conclusion 
The FAF should be regarded as a supplement to 
colour fundus images and has highest relevance 
when it comes to slow progressing conditions rather 
than acute conditions. Currently, the knowledge 
about what the FAF shows, and how it should be 
interpreted is broad and it seems likely that the tech-
nique will have a future not only in research and 
highly specialized retinal evaluations, but also in 
daily clinical work. IJOP  
Conflict of interests: this work has been performed 
without any financial compensation from Canon 
and we have no commercial interest in the Canon  
CR-2 PLUS™. However, our research group has 
ongoing collaboration with Canon Europe in other 
projects.